HÃ©lÃ¨ne GrangÃ©

Licensing officer at IRICoR â€” An Innovative Approach to Drug Discovery - Montreal, QC, CA

HÃ©lÃ¨ne GrangÃ©'s Colleagues at IRICoR â€” An Innovative Approach to Drug Discovery

Eric Jolicoeur

Agent de recherche

Contact Eric Jolicoeur

Remi-Martin Laberge

Vice - President, Scientific Operations

Contact Remi-Martin Laberge

Louise Regnier

Corporate Secretary

Contact Louise Regnier

Audrey Segret

Gestionnaire de projets

Contact Audrey Segret

Nadine Beauger

PrÃ©sidente-Directrice gÃ©nÃ©rale | President & Chief Executive Officer

Contact Nadine Beauger

View All HÃ©lÃ¨ne GrangÃ©'s Colleagues

HÃ©lÃ¨ne GrangÃ©'s Contact Details

Email (Verified)
***@iricor.ca

Get HÃ©lÃ¨ne GrangÃ©'s Email Address

Mobile Number
(XXX) XXX-XXXX

Get HÃ©lÃ¨ne GrangÃ©'s Mobile Number

Location
Montreal, Quebec, Canada

Company
IRICoR â€” An Innovative Approach to Drug Discovery

IRICoR â€” An Innovative Approach to Drug Discovery

Montreal, QC, CA • 10 - 19 Employees
BioTech/Drugs

IRICoR is a not-for-profit drug discovery and commercialization centre based at the Institute for Research in Immunology and Cancer (IRIC) on the Université de Montréal campus.Our main objective is to rapidly translate highly innovative scientific projects into high value novel therapies in oncology, immunology, and related indications through strong partnerships with the private sector — thereby efficiently bridging the innovation translation gap between early stage academic research and industry.

Drug discovery Drug development Licensing Partnerships Commercialization Medicinal chemistry Immunology and cancer research

Details about IRICoR â€” An Innovative Approach to Drug Discovery

HÃ©lÃ¨ne GrangÃ©'s email address is ***@iricor.ca. To view HÃ©lÃ¨ne GrangÃ©'s full email address, please signup to ConnectPlex.

HÃ©lÃ¨ne GrangÃ©'s colleagues at IRICoR â€” An Innovative Approach to Drug Discovery are Eric Jolicoeur, Ferima S., Gilles Derome, Remi-Martin Laberge, Louise Regnier, Audrey Segret, Nadine Beauger and others.